New Risk • Apr 10
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: kr92.0m (US$9.67m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Shareholders have been substantially diluted in the past year (33% increase in shares outstanding). Market cap is less than US$10m (kr92.0m market cap, or US$9.67m). Minor Risks Share price has been volatile over the past 3 months (9.8% average weekly change). Revenue is less than US$5m (kr15m revenue, or US$1.6m). Aankondiging • Feb 17
Induct AS, Annual General Meeting, Jun 11, 2027 Induct AS, Annual General Meeting, Jun 11, 2027. Reported Earnings • Feb 15
Full year 2025 earnings released: kr0.23 loss per share (vs kr0.87 loss in FY 2024) Full year 2025 results: kr0.23 loss per share (improved from kr0.87 loss in FY 2024). Revenue: kr16.6m (down 7.7% from FY 2024). Net loss: kr7.14m (loss narrowed 65% from FY 2024). Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has fallen by 7% per year, which means it is significantly lagging earnings. New Risk • Oct 06
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: kr98.3m (US$9.91m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 33% per year over the past 5 years. Shareholders have been substantially diluted in the past year (33% increase in shares outstanding). Market cap is less than US$10m (kr98.3m market cap, or US$9.91m). Minor Risks Share price has been volatile over the past 3 months (6.7% average weekly change). Revenue is less than US$5m (kr17m revenue, or US$1.7m). Reported Earnings • Aug 15
Second quarter 2025 earnings released Second quarter 2025 results: Revenue: kr4.89m (up 10.0% from 2Q 2024). Net loss: kr972.0k (loss widened 37% from 2Q 2024). New Risk • Jul 30
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Norwegian stocks, typically moving 12% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Earnings have declined by 29% per year over the past 5 years. Shareholders have been substantially diluted in the past year (33% increase in shares outstanding). Minor Risks Revenue is less than US$5m (kr17m revenue, or US$1.7m). Market cap is less than US$100m (kr132.8m market cap, or US$13.0m). New Risk • Jul 08
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 33% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 29% per year over the past 5 years. Shareholders have been substantially diluted in the past year (33% increase in shares outstanding). Minor Risks Share price has been volatile over the past 3 months (12% average weekly change). Revenue is less than US$5m (kr17m revenue, or US$1.7m). Market cap is less than US$100m (kr125.9m market cap, or US$12.5m). New Risk • Jun 26
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Norwegian stocks, typically moving 13% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (13% average weekly change). Earnings have declined by 29% per year over the past 5 years. Minor Risks Shareholders have been diluted in the past year (25% increase in shares outstanding). Revenue is less than US$5m (kr17m revenue, or US$1.7m). Market cap is less than US$100m (kr108.3m market cap, or US$10.8m). Aankondiging • May 27
Induct AS has completed a Follow-on Equity Offering in the amount of NOK 1.201458 million. Induct AS has completed a Follow-on Equity Offering in the amount of NOK 1.201458 million.
Security Name: Shares
Security Type: Common Stock
Securities Offered: 400,486
Price\Range: NOK 3
Transaction Features: Rights Offering Aankondiging • Apr 26
Induct AS has completed a Follow-on Equity Offering in the amount of NOK 14.449758 million. Induct AS has completed a Follow-on Equity Offering in the amount of NOK 14.449758 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 4,816,586
Price\Range: NOK 3
Transaction Features: Subsequent Direct Listing Reported Earnings • Apr 11
First quarter 2025 earnings released First quarter 2025 results: Revenue: kr5.23m (up 4.2% from 1Q 2024). Net loss: kr703.0k (loss narrowed 70% from 1Q 2024). Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has fallen by 13% per year, which means it is significantly lagging earnings. Reported Earnings • Feb 15
Full year 2024 earnings released: kr0.36 loss per share (vs kr0.27 loss in FY 2023) Full year 2024 results: kr0.36 loss per share (further deteriorated from kr0.27 loss in FY 2023). Revenue: kr21.0m (flat on FY 2023). Net loss: kr8.47m (loss widened 70% from FY 2023). Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has fallen by 14% per year, which means it is significantly lagging earnings. Recent Insider Transactions • Feb 09
Chief Executive Officer recently bought kr52k worth of stock On the 4th of February, Synnove Jacobsen bought around 10k shares on-market at roughly kr5.15 per share. This transaction amounted to 29% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Synnove's only on-market trade for the last 12 months. Aankondiging • Jan 28
Induct AS, Annual General Meeting, Jun 12, 2026 Induct AS, Annual General Meeting, Jun 12, 2026. Reported Earnings • Nov 17
Third quarter 2024 earnings released Third quarter 2024 results: Revenue: kr5.18m (down 4.6% from 3Q 2023). Net loss: kr3.50m (loss widened 129% from 3Q 2023). Reported Earnings • Aug 16
Second quarter 2024 earnings released Second quarter 2024 results: Revenue: kr5.14m (down 2.7% from 2Q 2023). Net loss: kr710.0k (loss narrowed 67% from 2Q 2023). New Risk • May 27
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 25% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (17% average weekly change). Earnings have declined by 6.2% per year over the past 5 years. Market cap is less than US$10m (kr91.9m market cap, or US$8.68m). Minor Risks Shareholders have been diluted in the past year (25% increase in shares outstanding). Revenue is less than US$5m (kr20m revenue, or US$1.9m). Reported Earnings • May 18
First quarter 2024 earnings released First quarter 2024 results: Revenue: kr5.71m (up 5.0% from 1Q 2023). Net loss: kr2.37m (loss widened 17% from 1Q 2023). Reported Earnings • Feb 16
Full year 2023 earnings released: kr0.47 loss per share (vs kr0.59 loss in FY 2022) Full year 2023 results: kr0.47 loss per share (improved from kr0.59 loss in FY 2022). Revenue: kr24.1m (up 33% from FY 2022). Net loss: kr8.80m (loss narrowed 14% from FY 2022). Over the last 3 years on average, earnings per share has fallen by 31% per year but the company’s share price has only fallen by 22% per year, which means it has not declined as severely as earnings. Reported Earnings • Nov 17
Third quarter 2023 earnings released Third quarter 2023 results: Revenue: kr6.33m (up 27% from 3Q 2022). Net loss: kr1.53m (loss widened 146% from 3Q 2022). Reported Earnings • Aug 18
Second quarter 2023 earnings released Second quarter 2023 results: Revenue: kr6.20m (up 24% from 2Q 2022). Net loss: kr2.13m (loss widened 369% from 2Q 2022). New Risk • Aug 01
New major risk - Market cap size The company's market capitalization is less than US$100m. Market cap: kr102.7m (US$10.0m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-kr25m free cash flow). Share price has been highly volatile over the past 3 months (17% average weekly change). Minor Risks Shareholders have been diluted in the past year (21% increase in shares outstanding). Revenue is less than US$5m (kr20m revenue, or US$2.0m). Market cap is less than US$100m (kr102.7m market cap, or US$10.0m). Aankondiging • Jun 24
Induct AS, Annual General Meeting, Jun 23, 2023 Induct AS, Annual General Meeting, Jun 23, 2023, at 14:00 Central European Standard Time. Location: Offices of the company in cort Adelersgate 17, 0254 Oslo Oslo Norway Agenda: To consider election of chairman of the meeting and a person to co-sign the protocol; to consider approval of notice and agenda; to consider approval of the board's proposal for annual accounts and annual report for 2022; to consider approval of remuneration for the board of directors; to consider appointment of board of directors; to consider approval of remuneration to auditor; to consider election of new auditor; to consider cancellation of previously issues power of attorney to the board of directors; and to consider granting of power of attorney to the board of directors for issuance of shares. Board Change • Jun 15
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 5 non-independent directors. Director Ole Karud was the last director to join the board, commencing their role in 2021. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. Recent Insider Transactions • Feb 20
Insider recently bought kr94k worth of stock On the 17th of February, Martin Fleisje bought around 18k shares on-market at roughly kr5.18 per share. This transaction amounted to 9.7% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was the only on-market transaction from insiders over the last 12 months. Reported Earnings • Feb 16
Full year 2022 earnings released Full year 2022 results: Revenue: kr21.4m (up 49% from FY 2021). Net loss: kr4.41m (loss narrowed 26% from FY 2021). Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has increased by 10% per year, which means it is well ahead of earnings. Board Change • Nov 24
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 5 non-independent directors. Director Ole Karud was the last director to join the board, commencing their role in 2021. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Aug 18
Second quarter 2022 earnings released Second quarter 2022 results: Revenue: kr5.30m (up 96% from 2Q 2021). Net loss: kr454.0k (loss narrowed 51% from 2Q 2021). Aankondiging • Jun 17
Induct AS, Annual General Meeting, Jun 22, 2022 Induct AS, Annual General Meeting, Jun 22, 2022, at 12:00 Central European Standard Time. Location: Cort Adelersgate 17 Oslo Norway Agenda: To consider Election of chairman of the meeting and a person to co-sign the protocol;Approval of remuneration for the board of directors; to consider approval of remuneration to auditor; to consider cancellation of previously issued power of attorney to the board of directors; to consider granting of power of attorney to the board of directors for issuance of shares; and to consider any other matters. Reported Earnings • May 13
First quarter 2022 earnings released First quarter 2022 results: Revenue: kr5.26m (up 126% from 1Q 2021). Net loss: kr721.0k (loss narrowed 27% from 1Q 2021). Board Change • Apr 27
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 5 non-independent directors. Director Ole Karud was the last director to join the board, commencing their role in 2021. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Feb 16
Full year 2021 earnings: Revenues in line with analyst expectations Full year 2021 results: Revenue: kr15.2m (up 31% from FY 2020). Net loss: kr1.84m (loss narrowed 15% from FY 2020). Revenue was in line with analyst estimates. Reported Earnings • Nov 02
Third quarter 2021 earnings released The company reported a mediocre third quarter result with weaker earnings and weaker control over costs, although revenues improved. Third quarter 2021 results: Revenue: kr5.01m (up 76% from 3Q 2020). Net loss: kr610.0k (down kr666.0k from profit in 3Q 2020). Executive Departure • Oct 03
Chairman of the Board of Directors Vibeke Madsen has left the company On the 27th of September, Vibeke Madsen's tenure as Chairman of the Board of Directors ended. We don't have any record of a personal shareholding under Vibeke's name. A total of 2 executives have left over the last 12 months. The current median tenure of the management team is 5.83 years. Executive Departure • Oct 03
Director Thomas Christensen has left the company On the 27th of September, Thomas Christensen's tenure as Director ended. We don't have any record of a personal shareholding under Thomas' name. A total of 2 executives have left over the last 12 months. The current median tenure of the management team is 5.83 years. Reported Earnings • Aug 18
Second quarter 2021 earnings released The company reported a soft second quarter result with weaker earnings and weaker control over costs, although revenues improved. Second quarter 2021 results: Revenue: kr2.70m (up 7.3% from 2Q 2020). Net loss: kr928.0k (down kr1.14m from profit in 2Q 2020). Recent Insider Transactions • May 12
Insider recently bought kr100k worth of stock On the 7th of May, Martin Fleisje bought around 12k shares on-market at roughly kr8.73 per share. This was the largest purchase by an insider in the last 3 months. This was the only on-market transaction from insiders over the last 12 months. Reported Earnings • May 04
First quarter 2021 earnings released The company reported a poor first quarter result with weaker earnings, revenues and control over costs. First quarter 2021 results: Revenue: kr2.33m (down 27% from 1Q 2020). Net loss: kr983.0k (down kr989.0k from profit in 1Q 2020). Over the last 3 years on average, earnings per share has increased by 80% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth. Reported Earnings • Feb 18
Full year 2020 earnings released: kr0.16 loss per share (vs kr0.57 loss in FY 2019) The company reported a decent full year result with reduced losses and improved control over expenses, although revenues were weaker. Full year 2020 results: Revenue: kr11.8m (down 15% from FY 2019). Net loss: kr1.95m (loss narrowed 69% from FY 2019). Over the last 3 years on average, earnings per share has increased by 70% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings. Is New 90 Day High Low • Feb 10
New 90-day high: kr11.50 The company is up 6.0% from its price of kr10.80 on 12 November 2020. The Norwegian market is up 14% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Software industry, which is up 29% over the same period. Is New 90 Day High Low • Dec 18
New 90-day low: kr7.50 The company is down 24% from its price of kr9.90 on 18 September 2020. The Norwegian market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Software industry, which is down 16% over the same period. Aankondiging • Nov 19
Induct Continues Facilitation of Innovation Indicator Project in Norwegian Health Authorities Induct has been awarded a contract to report on innovation activity and take the lead on a pilot to measure and report on innovation project benefits in all Norwegian health authorities. The contract value is NOK 400.000. excl. VAT. All regional health authorities and hospital trusts that are using the Induct platform will automatically adopt the indicator reporting practice through the Induct platform. This contract is a continuation of the announcement on 30 October 2018, where Induct was engaged to lead the national project to design a new method for measuring and reporting on innovation benefit across the Norwegian healthcare sector. The objective of the innovation indicators is to create incentives for hospital trusts and regional health authorities to invest in innovation capacity, create transparency and increase sharing of innovation initiatives across the sector. This will make it possible to link indicator results to central funding processes in the future and create even stronger incentives to work on, and share, innovation. Is New 90 Day High Low • Nov 11
New 90-day high: kr10.80 The company is up 110% from its price of kr5.15 on 13 August 2020. The Norwegian market is flat over the last 90 days, indicating the company outperformed over that time. It also outperformed the Software industry, which is down 14% over the same period. Is New 90 Day High Low • Oct 14
New 90-day high: kr10.50 The company is up 98% from its price of kr5.30 on 16 July 2020. The Norwegian market is up 4.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Software industry, which is up 21% over the same period. 
